Skip to main content
Log in

PERSPECTIVES IN PEDIATRIC PATHOLOGY: Progressive Familial Intrahepatic Cholestasis: A Personal Perspective

  • Published:
Pediatric and Developmental Pathology

ABSTRACT

Progressive familial intrahepatic cholestasis (PFIC), originally described as “Byler disease” in an Amish kindred, has been distinguished from other forms of cholestatic liver disease in childhood by clinical findings, clinical–laboratory observations, and morphologic studies in biopsy, hepatectomy, and autopsy specimens. Correlation with genetic analyses has permitted both more precise definition of PFIC and distinctions within PFIC. Two types of PFIC now are recognized: PFIC-1, resulting from mutations in a gene called FIC1 (familial intrahepatic cholestasis, type 1), and PFIC-2, resulting from mutations in a gene called BSEP (bile salt export pump). Other forms of PFIC may yet be identified. The roles of FIC1 and BSEP in the secretion of bile acids into bile and in the post-secretory modification of bile are under study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received September 1, 1999; accepted October 16, 1999.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knisely, A. PERSPECTIVES IN PEDIATRIC PATHOLOGY: Progressive Familial Intrahepatic Cholestasis: A Personal Perspective. Pediatr. Dev. Pathol. 3, 113–125 (2000). https://doi.org/10.1007/s100249910021

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100249910021

Navigation